Corrigendum to “E1K, a disease-modifying drug candidate for knee osteoarthritis, alleviates pain and regenerates cartilage simultaneously by inhibiting TGF-β1-mediated SMAD1/5/9 signaling in osteoarthritis models” [Osteoarthr. Cartil. 34 (2) (2026) 240–250]

Osteoarthritis and Cartilage 2026 Open access

Read full text
Authors: Eun-Joung Moon, Ji Ae Kim, Y.S. Jang, Hyeon-Jeong Kim, Hyeon-Jeong Kim, Sang-Je Park, Cheolmin Lee, Nam Sook Kang, Hae-Jin Kim, Hae-Jin Kim
DOI: 10.1016/j.joca.2026.01.632
Cited by: 0

Fields of Study & Subjects

Osteoarthritis Treatment and Mechanisms TGF-β signaling in diseases Proteoglycans and glycosaminoglycans research

Publication details

Journal / source
Osteoarthritis and Cartilage
Volume
34
Issue
4
Pages
641–642
Publication date
10 February 2026
Language
EN